Barclays’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.29M | Sell |
|
|||||
|
2025
Q2 | $1.26M | Buy |
|
|||||
|
2025
Q1 | $789K | Sell |
|
|||||
|
2024
Q4 | $975K | Buy |
|
|||||
|
2024
Q3 | $1.05M | Buy |
|
|||||
|
2024
Q2 | $148K | Sell |
|
|||||
|
2024
Q1 | $230K | Sell |
|
|||||
|
2023
Q4 | $540K | Buy |
|
|||||
|
2023
Q3 | $268K | Buy |
|
|||||
|
2023
Q2 | $110K | Sell |
|
|||||
|
2023
Q1 | $175K | Buy |
|
|||||
|
2022
Q4 | $71K | Buy |
|
|||||
|
2022
Q3 | $9K | Sell |
|
|||||
|
2022
Q2 | $15K | Sell |
|
|||||
|
2022
Q1 | $997K | Buy |
|
|||||
|
2021
Q4 | $1.05M | Sell |
|
|||||
|
2021
Q3 | $2.73M | Buy |
|
|||||
|
2021
Q2 | $30K | Sell |
|
|||||
|
2021
Q1 | $342K | Buy |
|
|||||
|
2020
Q4 | $1K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $1K | Sell |
|
|||||
|
2019
Q3 | $2K | Sell |
|
|||||
|
2019
Q2 | $155K | Buy |
|
|||||
|
2019
Q1 | $54K | Buy |
|
|||||
|
2018
Q4 | $48K | Sell |
|
|||||
|
2018
Q3 | $130K | Buy |
|
|||||
|
2018
Q2 | $19K | Buy |
|
|||||
|
2018
Q1 | $1K | Sell |
|
|||||
|
2017
Q4 | $368K | Sell |
|
|||||
|
2017
Q3 | $470K | Buy |
|
|||||
|
2017
Q2 | $262K | Hold |
|
|||||
|
2017
Q1 | $237K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $0 | Sell |
|
|||||
|
2015
Q2 | $1K | Sell |
|
|||||
|
2015
Q1 | $592K | Buy |
|
|||||
|
2014
Q4 | $28K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $2K | Buy |
|
|||||
|
2013
Q2 | $1K | Buy |
|